Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

SNDL Inc.

The cannabis industry in Canada contributes a significant amount to the budget of the country's most populous province. The legal marijuana industry is forecast to provide the equivalent of $445 million in taxes to Ontario this fiscal year.

Why Marijuana and CBD Stocks Were Buzzing Today

Canopy Growth Corp.'s stock continued its rally on Wednesday with a fresh rise of 28% on heavier-than-usual volume.

Canopy Growth rally continues with 28% gain after recent talk about federal cannabis reforms

Canopy Growth's stock has been soaring due to news about marijuana reform -- in Germany. A key shareholder vote scheduled for April 12 is crucial for the company.

Why April Could Be a Big Month for Canopy Growth

Aurora Cannabis

Tilray Brands

Cannabis stocks are climbing ahead of the German legalization date this Monday, April 1. Indeed, many of the biggest marijuana companies have soared as the country's long-awaited weed decriminalization process comes full circle.

Cannabis Stocks Heat Up Again Ahead of German Rollout

Cannabis stocks are continuing their recent rally, as legalization support continues to build in the U.S and overseas.

2 Cannabis Stocks to Watch Amid Germany Legalization

Cronos Group

Vice President Harris wants to legalize marijuana. Germany is legalizing marijuana.

Why Marijuana Stocks Are Hopping Again on Tuesday

Curaleaf Holdings, Inc.

In the last few years, cannabis stocks have been impacted by two factors. First, regulatory headwinds have played a spoilsport for an industry with huge potential.

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

As we continue Q2 2024, Canadian cannabis stocks are catching investors' eyes. This interest isn't just a trend. It's backed by solid growth in the global cannabis industry. Recent stats show remarkable expansion. By 2025, the industry could see revenues hitting $90 billion globally. This projection sparks enthusiasm among investors. They're keen to identify the top Canadian players. These companies are at the forefront of innovation and market penetration. Among them, some stand out for their strategic positioning and growth potential.

Top Picks: Canadian Cannabis Giants Set to Flourish in Q2 2024

Canopy Growth stock soared nearly 70% in a day last week on news that Germany will legalize weed. Canopy Growth applauded the move and described how it will capitalize on the legal marijuana market in Germany.

Why Canopy Growth Stock Dropped 9.5% Today

The coming legalization of marijuana in Germany should give a lift to pot stocks like Canopy Growth (NYSE: CGC ), Tilray (NASDAQ: TLRY ), Cronos (NASDAQ: CRON ), SNDL (NASDAQ: SNDL ) and Aurora Cannabis (NASDAQ: ACB ). So far, however, investors are facing a bad trip.

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

Canopy Growth Corporation (CGC) stock closed at $7.69 and is up $1.15 during pre-market trading. Pre-market trading tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.

Canopy Growth: CGC stock in focus as cannabis decriminalization talks gain momentum

Cannabis stocks were a bubble that exploded in 2021. The hype associated with anxious states legalizing cannabis and hopes for the federal repeal of marijuana legislation has lost momentum, but it may be starting up again.

2 Cannabis Stocks Clawing Back from the Grave, Germany Legalizes

OrganiGram Holdings Inc.

People who have been investing in marijuana stocks could soon a big change. Now this change is more from an industry standpoint which can in turn help how marijuana stocks trade. As most publicly traded companies news about the sector or individual company can impact trading. Marijuana stocks are no different in fact they can have a greater impact due to how volatile the sector can be. Nonetheless, it is yet to stop others from looking for the best marijuana stocks to buy.

The Marijuana Stocks Could See A Rise This Week

Canopy Growth is going up because Kamala Harris mentioned legalization in a meeting. Canopy Growth remains unprofitable and burns cash flow every quarter.

Why Canopy Growth Corporation Stock Soared 100% This Week

Cannabis stocks are absolutely ripping higher today. A range of Canada-based cannabis companies, including Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ) and Cronos (NASDAQ: CRON ) are up more than 7% in today's session, with Canopy Growth leading the way with a gain of almost 60%.

Dear Cannabis Stocks Fans, Mark Your Calendars for April 1

Canopy Growth Corp.'s stock has now doubled for its best week ever, with an added push coming after a historic vote in Germany on Friday in favor of decriminalizing cannabis.

Canopy Growth's stock doubles to record weekly gain after Germany votes to legalize pot

AdvisorShares Pure US Cannabis ETF

Canopy Growth led a weed stock rally early Friday after Germany legalized cannabis. New laws go into effect on April 1.

Canopy Growth, Weed Stocks Rocket After Germany Legalizes Cannabis

Vice President Kamala Harris endorsed marijuana legalization earlier this week, sending marijuana stocks flying higher. On Friday, marijuana investors got even better news: Germany will legalize weed on Easter Monday.

Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today

Removal of narcotic status for cannabis expected to accelerate growth of the German medical cannabis market  SMITHS FALLS, ON , March 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access. As of April 1, 2024, cannabis will officially be recognized as a non-narcotic in Germany, marking a monumental shift in the legal treatment and cultural acceptance of cannabis.

CANOPY GROWTH CELEBRATES PASSAGE OF CANNABIS LEGALIZATION IN GERMANY

Cannabis stocks cooled off Thursday but held onto big gains from the past week on the heels of positive comments from the Biden administration on reclassifying cannabis from a Schedule I controlled substance under federal law.

Cannabis stocks fall but hold onto big gains from the week on brighter federal reform prospects

Lucid Group

Peloton

Investors will always continue to chase weak stocks that are poorly rated for the chance at contrarian success. Yet, most times it is best to follow the herd when Wall Street repeatedly raises the warning flag on a given stock.

Red Alert! 3 Nasdaq Stocks Wall Street Is Warning Investors About.

Canopy Growth (NASDAQ: CGC ) is looking like a key beneficiary amid rising calls for federal marijuana policy reform. As of this writing, CGC stock has gained more than 10% on Wednesday.

Why Does Canopy Growth (CGC) Stock Keep Climbing This Week?

Canopy Growth stock led weed stocks higher early Wednesday. Shares continue rallying on Vice President Kamala Harris' call to reclassify marijuana.

Canopy Growth Stock Spikes, Weed Stocks Still Trade Higher Days After VP Harris Comments

Village Farms International

As we turn our attention to the Canadian cannabis sector and top marijuana stocks this week, it's hard not to notice the buzz it's creating among investors. With Canada leading the charge in legalizing cannabis for both medical and recreational use, its companies are now at the heart of a growing global market. This makes Canadian cannabis stocks particularly interesting to watch. They're not just a reflection of the thriving market at home; they symbolize Canada's prominent role on the world stage. The excitement is palpable as investors keep their eyes peeled for signs of growth and strategic international moves. Keeping up with market trends, regulatory shifts, and the competitive landscape is key to staying ahead.

Canadian Cannabis Stocks to Watch in Mid-March 2024

Scotts Miracle-Gro

While it's difficult to say with confidence who will win out in the elections later this year, investors of cannabis stocks may have something to look forward to. Basically, the attention should turn not to a possible red or blue wave but rather a green one.

News for Canopy Growth Stock (CGC)